17
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Residents Preferences for Pharmacist-Managed Clinic in China: A Discrete Choice Experiment

, , , &
Pages 1409-1422 | Received 02 Jan 2024, Accepted 14 Jun 2024, Published online: 02 Jul 2024

References

  • Service specifications for pharmacist-managed clinic in medical institutions; 2021.
  • Zhao X, Xu R, Wang Y, et al. Impacts of pharmacists-managed oncology outpatient clinic on resolving drug-related problems in ambulatory neoplasm patients: a prospective study in China. Inquiry. 2021:5800469580211009662. doi:10.1177/00469580211009662
  • Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy. 2001;21(11):1337–1344. doi:10.1592/phco.21.17.1337.34424
  • Seko T, Tachi T, Hatakeyama H, Noguchi Y, Teramachi H. Cost-effectiveness analysis and effectiveness of pharmacist-managed outpatient clinics in Helicobacter pylori eradication therapy. Int J Clin Pract. 2019;73(6):e13349. doi:10.1111/ijcp.13349
  • Pedersen CA, Schneider PJ, Ganio MC, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: dispensing and administration-2020. Am J Health-Syst Ph. 2021;78(12):1074–1093. doi:10.1093/ajhp/zxab120
  • Collins C, Kramer A, O’Day ME, Low MB. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center. Am J Health-Syst Ph. 2006;63(18):1723–1727. doi:10.2146/ajhp060098
  • de Barra M, Scott CL, Scott NW, et al. Pharmacist services for non-hospitalised patients. Cochrane Database Syst Rev. 2018;2018(9):Cd013102. doi:10.1002/14651858.Cd013102
  • Manzoor BS, Cheng W-H, Lee JC, Uppuluri EM, Nutescu EA. Quality of pharmacist-managed anticoagulation therapy in long-term ambulatory settings: a systematic review. Ann Pharmacother. 2017;51(12):1122–1137. doi:10.1177/1060028017721241
  • National technical specifications for medical service projects (2023 version); 2023.
  • Cai M, Zhou L, Gao D, et al. A national survey of individualized pharmaceutical care practice in Chinese hospitals in 2019. Front Pharmacol. 2023:141022134. doi:10.3389/fphar.2023.1022134
  • Xuerong Y, Yuanyuan H, Rou Y, Xiaoyan S, Yong Y. Practice of pharmacist-managed clinic and its promoting effect on medical quality in hospitals. Her Med. 2023;42(05):639–644.
  • Wenjie Z, Shu W, Bingrong G, Wei W, Yuan Z, Yueming H. Survey and analysis of patient satisfaction in pharmacist-managed clinic. Chin Remedies Clin. 2022;22(05):439–442.
  • Xin C, Xia Z, Jiang C, Lin M, Li G. The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study. Patient Prefer Adherence. 2016;10. doi:10.2147/ppa.S110167
  • Yufei L, Xuejia Q, Jingnan Y, Yue Z, Hongtao L, Zhanjun D. Practice of cough and asthma pharmacy outpatient service for patients with chronic obstructive pulmonary disease based on medication therapy management. Chin J Hospital Pharm. 2023;43(05):555–560. doi:10.13286/j.1001-5213.2023.05.15
  • Wu S-E, Wen M-J, Chen J-H, Shen W-C, Chang EH. A qualitative study on the development of pharmacist-managed clinics in Taiwan. J Clin Pharm Therapeutics. 2021;46(4):966–974. doi:10.1111/jcpt.13378
  • Alrasheedy AA, Hassali MA, Wong ZY, Saleem F. Pharmacist-managed medication therapy adherence clinics: the Malaysian experience. Res Social Administrative Pharm. 2017;13(4):885–886. doi:10.1016/j.sapharm.2017.02.011
  • Yamada K, Nabeshima T. Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives. J Pharm Health Care Sci. 2015;12. doi:10.1186/s40780-014-0001-4
  • Huan T, Yaqin D, Wei A, Fei X, Bingwu Z, Mingwei Z. Investigation on the current situation and influencing factors of outpatient pharmaceutical care clinic in our hospital. Chin Med Herald. 2022;19(09):55–58.
  • Siaw MYL, Toh JH, Lee JY-C. Patients’ perceptions of pharmacist-managed diabetes services in the ambulatory care and community settings within Singapore. Int J Clin Pharm-Net. 2018;40(2):403–411. doi:10.1007/s11096-018-0591-2
  • Vass C, Gray E, Payne K. Discrete choice experiments of pharmacy services: a systematic review. Int J Clin Pharm-Net. 2016;38(3):620–630. doi:10.1007/s11096-015-0221-1
  • Hong SH, Liu J, Wang J, Brown L, White-Means S. Conjoint analysis of patient preferences on medicare medication therapy management. J Am Pharm Assoc. 2011;51(3):378–387. doi:10.1331/JAPhA.2011.10039
  • Andreeva T, Danyliv A, Bondarenko K, Danyliv A. Preferences of people living with diabetes for the aspects of good pharmaceutical practice. Tobacco Control Public Health Eastern Europe. 2012;2. doi:10.6084/M9.FIGSHARE.92818
  • Bridges JFP, Hauber AB, Marshall D, et al. Conjoint analysis applications in health-a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14(4):403–413. doi:10.1016/j.jval.2010.11.013
  • Johnson FR, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3–13. doi:10.1016/j.jval.2012.08.2223
  • Hauber AB, Gonzalez JM, Groothuis-Oudshoorn CGM, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300–315. doi:10.1016/j.jval.2016.04.004
  • Wyatt H, Zuckerman AD, Hughes ME, Arnall J, Miller R. Trial standards for pharmacist-managed clinic. Pharm Today. 2018;28(11):721–726.
  • Manlu G. Research on Incentive Mechanism of Primary Health Care Personnel in Ningxia - Analysis Based on Discrete Choice Experiment. Ningxia Medical University; 2015.
  • de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient Center Outcomes Res. 2015;8(5):373–384. doi:10.1007/s40271-015-0118-z
  • Xinyi Z, Qing W, Ning-jia T, et al. A national online survey of pharmacist-managed clinics in tertiary hospitals in China. Chin Pharm J. 2021;56(10):849–853.
  • Hole AR. Fitting mixed logit models by using maximum simulated likelihood. Stata J. 2007;7(3):388–401. doi:10.1177/1536867x0700700306
  • Lancsar E, Louviere J, Flynn T. Several methods to investigate relative attribute impact in stated preference experiments. Soc sci med. 2007;64(8):1738–1753. doi:10.1016/j.socscimed.2006.12.007
  • Nan W, Mengyue L, Yanping L, Jingyi M. Survey on patients’ awareness and willingness to pay for pharmacist-managed clinic in Tianjin tertiary hospitals and analysis of influencing factors. Tianjin Pharm. 2019;31(03):39–45.
  • Hu Q, Hu H, Hu M, Yang Y, Wu Z, Zhou N. Patient preferences for specialty pharmacy services: a stated preference discrete-choice experiment in China. Front Public Health. 2020;8597389. doi:10.3389/fpubh.2020.597389
  • Hwang AY, Gums TH, Gums JG. The benefits of physician-pharmacist collaboration. J Fam Pract. 2017;66(12):E1–e8.
  • Matzke GR, Moczygemba LR, Williams KJ, Czar MJ, Lee WT. Impact of a pharmacist-physician collaborative care model on patient outcomes and health services utilization. Am J Health Syst Pharm. 2018;75(14):1039–1047. doi:10.2146/ajhp170789
  • Harris IM, Baker E, Berry TM, et al. Developing a business-practice model for pharmacy services in ambulatory settings. Pharmacotherapy. 2008;28(2):285. doi:10.1592/phco.28.2.285
  • Thompson CA. Physician leaders hear details on pharmacist collaborative drug therapy management. Am J Health-Syst Ph. 2001;58(10):843–+. doi:10.1093/ajhp/58.10.843
  • Porteous T, Ryan M, Bond C, Watson M, Watson VMMA. The public’s preferences for attributes of community pharmacies. A discrete choice experiment. PLoS One. 2016;11(3):e0152257. doi:10.1371/journal.pone.0152257
  • Feehan M, Walsh M, Godin J, Sundwall D, Munger MA. Patient preferences for healthcare delivery through community pharmacy settings in the USA: a discrete choice study. J Clin Pharm Therapeutics. 2017;42(6):738–749. doi:10.1111/jcpt.12574
  • Presley B, Groot W, Widjanarko D, Pavlova M. Preferences for pharmacist services to enhance medication management among people with diabetes in Indonesia: a discrete choice experiment. Patient Educ Couns. 2021;104(7):1745–1755. doi:10.1016/j.pec.2020.12.005
  • Patterson JA, Holdford DA, Harpe SE. Patient preferences for objective quality metrics during community pharmacy selection: a discrete choice experiment. Res Soc Administr Pharm. 2019;15(6):641–649. doi:10.1016/j.sapharm.2018.08.002
  • Jun Q, Jiankang Y, Jie P. Investigation of the awareness status and pharmaceutical needs of patients in pharmacy outpatient clinics at 14 medical institutions in Suzhou. Her Med. 2023;42(08):1165–1171.
  • Luli AJ, Awdishu L, Hirsch JD, Watanabe JH, Bounthavong M, Morello CM. Transferring Key Success Factors from Ambulatory Care into the Community Pharmacy in the United States. Pharmacy. 2021;9(3). doi:10.3390/pharmacy9030116
  • AlShayban DM, Naqvi AA, Islam MA, et al. Patient satisfaction and their willingness to pay for a pharmacist counseling session in hospital and community pharmacies in Saudi Healthcare Settings. Front Pharmacol. 2020;11:138. doi:10.3389/fphar.2020.00138
  • Steckowych K, Smith M, Spiggle S, Stevens A, Li H. Building the case: changing consumer perceptions of the value of expanded community pharmacist services. J Pharm Pract. 2019;32(6):637–647. doi:10.1177/0897190018771521
  • McMillan SS, Kelly F, Sav A, King MA, Awhitty J, Wheeler AJ. Australian community pharmacy services: a survey of what people with chronic conditions and their carers use versus what they consider important. BMJ Open. 2014;4(12):e006587. doi:10.1136/bmjopen-2014-006587
  • Naik Panvelkar P, Armour C, Saini B. Community pharmacy-based asthma services--what do patients prefer? J Asthma. 2010;47(10):1085–1093. doi:10.3109/02770903.2010.514638
  • Twigg MJ, Poland F, Bhattacharya D, Desborough JA, Wright DJ. The current and future roles of community pharmacists: views and experiences of patients with type 2 diabetes. Res Social Adm Pharm. 2013;9(6):777–789. doi:10.1016/j.sapharm.2012.10.004
  • ASHP guidelines on pharmacist-conducted patient education and counseling. Guideline; Practice Guideline. AJHP. 1997;54(4):431–434.
  • Cvetkovski B, Armour C, Bosnic-Anticevich S. Asthma management in rural New South Wales: perceptions of health care professionals and people with asthma. Aust J Rural Health. 2009;17(4):195–200. doi:10.1111/j.1440-1584.2009.01071.x